Please assess the completion status of the following clinical trial:

Trial Title: Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 18 and 35 years (inclusive), in good general health and requesting contraception.~* Has regular menstrual cycles (length of cycle 21-35 days) (i.e., endogenous cyclicity without hormonal contraceptive use).~Exclusion Criteria:~* Known or suspected pregnancy or is lactating.~* History of ectopic pregnancies.~* Any genital infection (until successfully treated).~* Abnormal uterine bleeding of unknown origin.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- LCS12 (Type: EXPERIMENTAL): Intrauterine levonorgestrel contraceptive system (LCS), releasing levonorgestrel (LNG) 12 microg/24 h in vitro
- LCS16 (Type: EXPERIMENTAL): Intrauterine levonorgestrel contraceptive system (LCS), releasing levonorgestrel (LNG) 16 microg/24 h in vitro

Based on this trial design, predict the completion outcome and termination type (if applicable).